Exposure to systemic prednisolone for 4 hours reduces ex vivo synthesis of GM-CSF by bronchoalveolar lavage cells and blood mononuclear cells of mild allergic asthmatics

Clinical and Experimental Allergy

Volumn 29, Issue 12, 1999, Pages 1655-1662

  Cotter, T P ^a   Hood, P P ^a   Costello, J F ^a   Sampson, A P ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; Bronchoalveolar lavage; Bronchoscopy; Glucocorticoids; Granulocytemacrophage colony stimulating factor; Lymphocytes; Macrophages; Monocytes

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PRECORTOLAN; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; LUNG LAVAGE; MONONUCLEAR CELL; PRIORITY JOURNAL; STEROID THERAPY;

ADULT; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; DOUBLE-BLIND METHOD; GLUCOCORTICOIDS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MACROPHAGES; MONOCYTES; PREDNISOLONE;

EID: 0033401606     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00674.x     Document Type: Article

References (42)

1. 1 Lopez AF, Williamson JR, Gamble JR et al. Recombinant human granulocyte-macrophage colony stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 1986; 78:1220-8.
2. 2 Silberstein DS, Owen WF, Gasson JC et al. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony stimulating factor. J Immunol 1986; 137:3290-4.
3. 3 Tomioka K, MacGlashan DW, Lichtenstein LM, Bochner BS, Schleimer RP. GM-CSF regulates human eosinophil responses to f-met peptide and platelet activating factor. J Immunol 1993; 151:4989-97.
4. 4 synthesis. J Immunol 1988; 140:4315-22.
5. 5 Matz J, Williams J, Rosenwasser LJ, Borish LC. Granulocyte-macrophage colony stimulating factor stimulates macrophages to respond to IgE via the low affinity IgE receptor (CD23). J Allergy Clin Immunol 1994; 93:650-7.
6. 6 Sarmiento EU, Espiritu BR, Gleich GJ, Thomas LL. IL-3, IL-5, and granulocyte-macrophage colony stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein. J Immunol 1995; 155: 2211-21.
7. 7 Brock TG, McNish RW, Coffey MJ, Ojo TC, Phare SM, Peters-Golden M. Effects of granulocyte-macrophage colony stimulating factor on eicosanoid production by mononuclear phagocytes. J Immunol 1996; 156:2522-7.
8. 8 Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest 1994; 105:687-96.
9. 9 Sousa AR, Poston RN, Lane SJ, Nakhosteen JA, Lee TH. Detection of granulocyte-macrophage colony stimulating factor in asthmatic bronchial epithelium and decrease by inhaled steroids. Am Rev Respir Dis 1993; 147:1557-61.
10. 10 Woolley KL, Adelroth E, Woolley MJ, Ellis R, Jordana M, O'Byrne PM. Granulocyte-macrophage colony stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma. Eur Respir J 1994; 7:1576-84.
11. 11 Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin 5 and granulocyte macrophage colony stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992; 90:1414-24.
12. 12 Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage colony stimulating factor, interleukin-6 and IL-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992; 89:1001-9.
13. 13 Robinson DS, Hamid Q, Ying S et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
14. 14 Robinson DS, Ying S, Bentley AM et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993; 92:397-403.
15. 15 Broide DH, Firestein GS. Endobronchial allergen challenge in asthma. Demonstration of cellular source of granulocyte-macrophage colony stimulating factor by in situ hybridization. J Clin Invest 1991; 88:1048-53.
16. 16 Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992; 89:958-67.
17. 17 Bentley AM, Meng Q. Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte-macrophage colony stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993; 8:35-42.
18. 18 Virchow J, Walker C, Hafner D et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995; 151:960-8.
19. 19 Sim TC, Grant JA, Hilsmeier KA, Fukuda Y, Alam R. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med 1994; 149:339-44.
20. 20 Brown PH, Crompton GK, Greening AP. Proinflammatory cytokines in acute asthma. Lancet 1991; 338:590-3.
21. 21 Cox G, Ohtoshi T, Vancheri C et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 1991; 4:525-31.
22. 22 Nakamura Y, Ozaki T, Kamei T et al. Increased granulocyte-macrophage colony stimulating factor production by mononuclear cells from peripheral blood of patients with bronchial asthma. Am Rev Respir Dis 1993; 147:87-91.
23. 23 Saunders MA, Mitchell JA, Seldon PM et al. Release of GM-CSF by human cultured airway smooth muscle cells: suppression by dexamethasone. Br J Pharmacol 1997; 120: 545-6.
24. 24 Djukanovic R, Wilson JW, Britten KM et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992; 145:669-74.
25. 25 Trigg CJ, Manolitsas ND, Wang J et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994; 150:17-22.
26. 26 Wang JH, Trigg CJ, Devalia JL, Jordan S, Davies RJ. Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthma. J Allergy Clin Immunol 1994; 94:1025-34.
27. 27 Corrigan CJ, Hamid Q, North J et al. Peripheral blood CD4 but not CD8 T-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 1995; 12:567-78.
28. 28 Littenberg B, Gluck EH. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med 1986; 314:150-2.
29. 29 Storr J, Barrell E, Barry W, Lenney W, Hatcher G. Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet 1987; i:879-82.
30. 30 Fanta CH, Rossing TH, McFadden ER. Glucocorticoids in acute asthma. Am J Med 1983; 74:845-51.
31. 31 Younger RE, Gerber PS, Herrod HG, Cohen RM, Crawford LV. Intravenous methylprednisolone efficacy in status asthmaticus of childhood. Pediatrics 1987; 80:225-30.
32. 32 Shapiro GG, Furukawa CT, Pierson WE, Gardiner R, Bierman CW. Double-blind evaluation of methylprednisolone versus placebo for acute asthma episodes. Pediatrics 1983; 71:510-4.
33. 33 Kato M, Schleimer RP. Anti-inflammatory steroids inhibit granulocyte-macrophage colony stimulating factor production by human lung tissue. Lung 1994; 172:113-24.
34. 34 Restrick LJ, Sampson AP, Piper PJ, Costello JF. Inulin as a marker of dilution of bronchoalveolar lavage in asthmatic and normal subjects. Am J Respir Crit Care Med 1995; 151:1211-7.
35. 35 McFadden ER. Dosages of corticosteroids in asthma. Am Rev Respir Dis 1993; 147:1306-1 0.
36. 36 National Institutes of Health. Global initiative for asthma: global strategy for asthma management and prevention. NHBLI/WHO Workshop NIH Publication 96-3659B, 1995.
37. 37 Fahy JV, Kim KK, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995; 95:843-52.
38. 38 Poston RN, Chanez P, Lacoste JY, Litchfield T, Lee TH, Bousquet J. Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis 1992; 145:918-21.
39. 39 Kita H, Ohnishi T, Okubo Y, Weiler D, Abrams JS, Gleich GJ. Granulocyte-macrophage colony stimulating factor and interleukin-3 release from human peripheral blood eosinophils and neutrophils. J Exp Med 1991; 174:745-8.
40. 40 Catena E, Mazzarella G, Peluso GF, Micheli P, Cammarata A, Marsico SA. Phenotypic features and secretory pattern of alveolar macrophages in atopic asthmatic patients. Monaldi Arch Chest Dis 1993; 48:6-15.
41. 41 Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993; 14:436-41.
42. 42 Musso M, Ghiarzo P, Fiorentini P et al. An upstream positive regulatory element in the human GM-CSF promoter is recognised by NF-κB/Rel family members. Biochem Biophys Res Commun 1996; 223:64-72.